deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT02580214

Immunonutrition in Total Hip Arthroplasty (Immunehip)

A Protocol Of Perioperative Care Plus Immunonutrition Enhances Recovery After Total Hip Arthroplasty. A Randomized Pilot Study

Sponsor: Federal University of Mato Grosso

Interventions Impact
Updated 7 times since 2017 Last updated: Oct 19, 2015 Started: May 31, 2013 Primary completion: Mar 31, 2014 Completion: Nov 30, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Arthroplasty, Hip Replacement and Nutritional Support, this trial is completed. The trial is conducted by Federal University of Mato Grosso and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~May 2020 · 23 months · monthly snapshotCompleted~May 2020 – ~Jan 2021 · 8 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3PHASE2/PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  5. May 2020 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

Show 2 earlier versions
  1. Jun 2018 — May 2020 [monthly]

    Completed PHASE2_PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

    First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Federal University of Mato Grosso
Data source: Federal University of Mato Grosso

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations